Evidence map›Paper›PMID 31780880›Full record

ArticleFrontiers in neuroscience2019

Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients.

Ana Fernández-Marmiesse, Iria Roca, Felícitas Díaz-Flores, Verónica Cantarín, Mª Socorro Pérez-Poyato, Ana Fontalba, Francisco Laranjeira, Sofia Quintans, Oana Moldovan, Blanca Felgueroso and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. CharacterizingmedRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Distinct Regulation of Early Trafficking of the NMDA Receptors by the Ligand-Binding Domains of the GluN1 and GluN2A Subunits.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Expanding the phenotypic spectrum of DNM1-related disorders: novel GTPase domain variants and their diverse neurological outcomes.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  8. A Novel Loss of Function Variant inMolecular syndromology · 2025
    Article
  9. Article
  10. Article
  11. Novel KCNQ2 missense variant expands the genotype spectrum of DEE7.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Frontiers in neurology · 2024
    Article
  16. Experience with the Ketogenic Diet in a Boy withBalkan journal of medical genetics : BJMG · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 14 institutions in 2 countries.

Ana Fernández-MarmiesseUnit for the Diagnosis and Treatment of Congenital Metabolic Diseases, Clinical University Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Iria RocaUnit for the Diagnosis and Treatment of Congenital Metabolic Diseases, Clinical University Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Felícitas Díaz-FloresMolecular Genetics Unit, Clinical University Hospital of Canarias, Santa Cruz de Tenerife, Spain.
Verónica CantarínNeuropediatrics Unit, Niño Jesús Clinical University Hospital, Madrid, Spain.
Mª Socorro Pérez-PoyatoNeuropediatrics Unit, Marqués de Valdecilla Clinical University Hospital, Santander, Spain.
Ana FontalbaGenetics Unit, Marqués de Valdecilla Clinical University Hospital, Santander, Spain.
Francisco LaranjeiraCentro de Genética Médica Jacinto Magalhães, Centro Hospitalar Do Porto, Porto, Portugal.
Sofia QuintansNeuropediatrics Unit, Santa María Hospital, Lisbon, Portugal.
Oana MoldovanGenetics Unit, Santa María Hospital, Lisbon, Portugal.
Blanca FelguerosoNeuropediatrics Unit, Teresa Herrera Child's Hospital, A Coruña, Spain.
Montserrat Rodríguez-PedreiraClinical Genetics Unit, Teresa Herrera Child's Hospital, A Coruña, Spain.
Rogelio SimónNeuropediatrics Unit, 12 de Octubre Clinical University Hospital, Madrid, Spain.
Ana CamachoNeuropediatrics Unit, 12 de Octubre Clinical University Hospital, Madrid, Spain.
Pilar QuijadaMetabolic Disorders Unit, 12 de Octubre Clinical University Hospital, Madrid, Spain.
Salvador Ibanez-MicoNeuropediatrics Unit, Virgen de la Arrixaca Clinical University Hospital, Murcia, Spain.
Mª Rosario DomingnoNeuropediatrics Unit, Virgen de la Arrixaca Clinical University Hospital, Murcia, Spain.
Carmen BenitoGenetics Unit, Clinical University Hospital of Málaga, Málaga, Spain.
Rocío CalvoNeuropediatrics Unit, Clinical University Hospital of Málaga, Málaga, Spain.
Antonia Pérez-CejasMolecular Genetics Unit, Clinical University Hospital of Canarias, Santa Cruz de Tenerife, Spain.
Mª Llanos CarrascoNeuropediatrics Unit, Clinical University Hospital Severo Ochoa, Leganés, Madrid, Spain.
Feliciano RamosClinical Genetics Unit, Pediatrics, Clinical University Hospital of Zaragoza, Zaragoza, Spain.
Mª Luz CouceUnit for the Diagnosis and Treatment of Congenital Metabolic Diseases, Clinical University Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
Mª Luz Ruiz-FalcóNeuropediatrics Unit, Niño Jesús Clinical University Hospital, Madrid, Spain.
Luis Gutierrez-SolanaNeuropediatrics Unit, Niño Jesús Clinical University Hospital, Madrid, Spain.
Margarita Martínez-AtienzaGenomes & Disease Group, Molecular Medicine and Chronic Diseases Research Centre (CiMUS), Santiago de Compostela University-IDIS, Santiago de Compostela, Spain.
Hospital Infantil Universitario Niño Jesús · ESCenter for Research in Molecular Medicine and Chronic Diseases · ESHospital de Santa Maria · PTHospital Universitario de Canarias · ESHospital Universitario Virgen de la Arrixaca · ESMarqués de Valdecilla University Hospital · ESResearch Institute Hospital 12 de Octubre · ESUniversidad de Málaga · ESCentro Hospitalar do Porto · PTHospital Universitario Severo Ochoa · ESHospital Universitario Virgen de las Nieves · ESInstituto de Investigación Sanitaria de Santiago · ESUniversidad Complutense de Madrid · ESUniversidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to characterize the genetic architecture of epilepsy in a pediatric population from the Iberian Peninsula (including the Canary Islands), we conducted targeted exome sequencing of 246 patients with infantile-onset seizures with or without neurodevelopmental delay. We detected 107 variants in 48 different genes, which were implicated in neuronal excitability, neurodevelopment, synaptic transmission, and metabolic pathways. In 104 cases (42%) we detected variant(s) that we classified as pathogenic or likely pathogenic. Of the 48 mutated genes, 32 were dominant, 8 recessive and 8 X-linked. Of the patients for whom family studies could be performed and in whom pathogenic variants were identified in dominant or X-linked genes, 82% carried

Indexed as

de novo mutationsepilepsygenetic diagnosisincomplete penetrancemodifier genesneurodevelopmental disorders

Identifiers

PMID31780880
PMCPMC6856296
OpenAlexW2981628160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.